BlackRock’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.03M | Buy |
|
|||||
|
2024
Q1 | $2.9M | Sell |
|
|||||
|
2023
Q4 | $2.08M | Sell |
|
|||||
|
2023
Q3 | $1.61M | Sell |
|
|||||
|
2023
Q2 | $2.95M | Sell |
|
|||||
|
2023
Q1 | $3.72M | Sell |
|
|||||
|
2022
Q4 | $8.1M | Sell |
|
|||||
|
2022
Q3 | $19M | Buy |
|
|||||
|
2022
Q2 | $6.76M | Sell |
|
|||||
|
2022
Q1 | $25.1M | Sell |
|
|||||
|
2021
Q4 | $33.8M | Buy |
|
|||||
|
2021
Q3 | $43.5M | Buy |
|
|||||
|
2021
Q2 | $70.9M | Buy |
|
|||||
|
2021
Q1 | $75.8M | Buy |
|
|||||
|
2020
Q4 | $52.1M | Buy |
|
|||||
|
2020
Q3 | $30.4M | Sell |
|
|||||
|
2020
Q2 | $65.1M | Buy |
|
|||||
|
2020
Q1 | $28.4M | Sell |
|
|||||
|
2019
Q4 | $68.2M | Sell |
|
|||||
|
2019
Q3 | $58.9M | Buy |
|
|||||
|
2019
Q2 | $75.7M | Buy |
|
|||||
|
2019
Q1 | $32.2M | Sell |
|
|||||
|
2018
Q4 | $37.6M | Buy |
|
|||||
|
2018
Q3 | $96M | Buy |
|
|||||
|
2018
Q2 | $73.5M | Buy |
|
|||||
|
2018
Q1 | $47.5M | Buy |
|
|||||
|
2017
Q4 | $14.8M | Buy |
|
|||||
|
2017
Q3 | $8.69M | Buy |
|
|||||
|
2017
Q2 | $187K | Buy |
|